Skip to main content

Peer Review reports

From: Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis

Original Submission
13 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Jun 2023 Reviewed Reviewer Report - Yingshi Zhang
17 Jun 2023 Reviewed Reviewer Report - Yang Ke
16 Sep 2023 Author responded Author comments - Huilin Xu
Resubmission - Version 3
16 Sep 2023 Submitted Manuscript version 3
4 Oct 2023 Reviewed Reviewer Report - Yang Ke
6 Oct 2023 Reviewed Reviewer Report - Yingshi Zhang
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Oct 2023 Editorially accepted
19 Oct 2023 Article published 10.1186/s12885-023-11488-9

You can find further information about peer review here.

Back to article page